<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>49(5)</volume><submitter>Hagman E</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The integration of mobile health technology with physical visits shows promising one-year treatment outcomes, but long-term evidence is lacking.&lt;h4>Objectives&lt;/h4>To assess three-year treatment outcomes for patients utilizing the digital treatment tool Evira in combination with physical visits, compared with standard obesity care.&lt;h4>Methods&lt;/h4>In a pragmatic trial, children with obesity aged 4.0-17.9 years receiving digi-physical treatment with Evira (n = 107) were compared with a group receiving standard treatment (n = 321). Evira comprises a digitless body scale for home-weighing, a mobile application, and a web-based clinic interface, enabling easy family-clinic communication and continuous visual treatment feedback.&lt;h4>Results&lt;/h4>At the three-year follow-up, the a</pubmed_abstract><journal>International journal of obesity (2005)</journal><pagination>973-976</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12095034</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-term results of a digital treatment tool as an add-on to pediatric obesity lifestyle treatment: a 3-year pragmatic clinical trial.</pubmed_title><pmcid>PMC12095034</pmcid><pubmed_authors>Hagman E</pubmed_authors><pubmed_authors>Putri RR</pubmed_authors><pubmed_authors>Lindberg L</pubmed_authors><pubmed_authors>Drangel A</pubmed_authors><pubmed_authors>Danielsson P</pubmed_authors><pubmed_authors>Marcus C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term results of a digital treatment tool as an add-on to pediatric obesity lifestyle treatment: a 3-year pragmatic clinical trial.</name><description>&lt;h4>Background&lt;/h4>The integration of mobile health technology with physical visits shows promising one-year treatment outcomes, but long-term evidence is lacking.&lt;h4>Objectives&lt;/h4>To assess three-year treatment outcomes for patients utilizing the digital treatment tool Evira in combination with physical visits, compared with standard obesity care.&lt;h4>Methods&lt;/h4>In a pragmatic trial, children with obesity aged 4.0-17.9 years receiving digi-physical treatment with Evira (n = 107) were compared with a group receiving standard treatment (n = 321). Evira comprises a digitless body scale for home-weighing, a mobile application, and a web-based clinic interface, enabling easy family-clinic communication and continuous visual treatment feedback.&lt;h4>Results&lt;/h4>At the three-year follow-up, the a</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-01T19:15:31.353Z</modification><creation>2026-05-21T03:08:47.963Z</creation></dates><accession>S-EPMC12095034</accession><cross_references><pubmed>40075128</pubmed><doi>10.1038/s41366-025-01738-0</doi></cross_references></HashMap>